Orthopediatrics (KIDS) versus Invuity (IVTY) Head to Head Contrast

Share on StockTwits

Orthopediatrics (NASDAQ: KIDS) and Invuity (NASDAQ:IVTY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk.

Valuation & Earnings

This table compares Orthopediatrics and Invuity’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Orthopediatrics $45.62 million 7.72 -$8.93 million ($5.70) -4.84
Invuity $39.62 million 2.19 -$39.91 million ($2.20) -1.64

Orthopediatrics has higher revenue and earnings than Invuity. Orthopediatrics is trading at a lower price-to-earnings ratio than Invuity, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

35.4% of Orthopediatrics shares are held by institutional investors. Comparatively, 57.8% of Invuity shares are held by institutional investors. 46.1% of Orthopediatrics shares are held by company insiders. Comparatively, 8.4% of Invuity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Orthopediatrics and Invuity, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthopediatrics 0 0 4 0 3.00
Invuity 0 0 3 0 3.00

Orthopediatrics currently has a consensus target price of $25.67, indicating a potential downside of 6.97%. Invuity has a consensus target price of $7.67, indicating a potential upside of 112.96%. Given Invuity’s higher probable upside, analysts plainly believe Invuity is more favorable than Orthopediatrics.

Profitability

This table compares Orthopediatrics and Invuity’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Orthopediatrics -61.99% -450.97% -43.68%
Invuity -89.29% -837.22% -71.82%

Summary

Orthopediatrics beats Invuity on 8 of the 12 factors compared between the two stocks.

Orthopediatrics Company Profile

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems. Its products are used in the pediatric trauma and deformity procedures, as well as scoliosis procedures for the treatment of spinal deformity. The company serves pediatric orthopedic market, as well as caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.

Invuity Company Profile

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply